22 related articles for article (PubMed ID: 19656666)
1. Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer.
Jagsi R; Ward KC; Abrahamse PH; Wallner LP; Kurian AW; Hamilton AS; Katz SJ; Hawley ST
Cancer; 2018 Sep; 124(18):3668-3676. PubMed ID: 30033631
[TBL] [Abstract][Full Text] [Related]
2. Survey of spinal therapeutic procedures in the United Kingdom.
Okafor BE; Sullivan MF
Eur Spine J; 1997; 6(5):294-7. PubMed ID: 9391797
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant! Online as a decision-making tool in early breast cancer--a UK national survey.
Agarwal V; O'Neill P
Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):159-60. PubMed ID: 21112194
[No Abstract] [Full Text] [Related]
4. Adjuvant chemotherapy in node negative breast cancer: patterns of use and oncologists' preferences.
Stiggelbout AM; de Haes JC; van de Velde CJ
Ann Oncol; 2000 May; 11(5):631-3. PubMed ID: 10907961
[TBL] [Abstract][Full Text] [Related]
5. A national survey investigating UK prescribers' opinions on chemotherapy dosing and 'dose-banding'.
Kaestner SA; Sewell GJ
Clin Oncol (R Coll Radiol); 2009 May; 21(4):320-8. PubMed ID: 19201584
[TBL] [Abstract][Full Text] [Related]
6. Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom.
Lester JE; Dodwell D; Horsman JM; Mori S; Coleman RE
Br J Cancer; 2006 Jan; 94(1):30-5. PubMed ID: 16317429
[TBL] [Abstract][Full Text] [Related]
7. Which bisphosphonates do oncologists prescribe for women with metastatic breast cancer and why? Results of a UK survey.
Fallowfield L; Jenkins V; Coleman R
Breast; 2008 Oct; 17(5):459-63. PubMed ID: 18455921
[TBL] [Abstract][Full Text] [Related]
8. Management of morphoea: results of a national survey of U.K. clinicians.
Warburton KL; McPhee MJ; Savage LJ; Honan AE; Montgomery R; Ghazavi M; Torley D; Shams K; Ingram JR
Br J Dermatol; 2014 Nov; 171(5):1243-5. PubMed ID: 24749777
[No Abstract] [Full Text] [Related]
9. Management of sinonasal cancers: Survey of UK practice and literature overview.
Iyizoba-Ebozue Z; Fleming JC; Prestwich RJD; Thomson DJ
Eur J Surg Oncol; 2022 Jan; 48(1):32-43. PubMed ID: 34840009
[TBL] [Abstract][Full Text] [Related]
10. [Neo-adjuvant chemotherapy of malignant tumors (based on the materials presented on the 9th congress of the oncologists of the Ukraine)].
Savran VR; Nekhme A; Savran VV
Klin Khir; 1998; (5):36-40. PubMed ID: 9787572
[No Abstract] [Full Text] [Related]
11. Variation in early breast cancer systemic adjuvant therapy practice among UK oncologists with potential impact on patient benefit and the financial burden: national postal questionnaire survey.
Moe MM
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):734-5. PubMed ID: 19656666
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
